It is often the indignation of the general public that pharmaceutical companies take advantage of the desperate situation of patients and their relatives by taking advantage of the price tags for medicines for deadly diseases. For example, cancer chemotherapy can cost millions of dollars.
But this is not about the bloodthirsty nature of pharmaceutical companies, but about simple commercial calculation. Investing in the development and promotion of a new drug, whether antibiotic or anti-cancer, is standard – from hundreds of millions to billions of dollars. However, while the first class of drugs is potentially in demand by virtually all people on the planet, cancer is relatively rare. Investors do not care about these differences – investments must be repayable in the same time frame. In short, if the incidence of dysbacteriosis was 1 per 100,000 inhabitants, it would cost huge sums of money and would be used in extreme and deadly cases.
Don’t hurt yourself!